newsfilter
← Latest News
ACCESS Newswire·

Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq

NEW YORK CITY, NY / ACCESS Newswire / February 19, 2025 / Aspire Biopharma, Inc. , a developer of a multi-faceted patent-protected disruptive drug delivery mechanism